ARTICLE | Company News
GlaxoSmithKline, NIH deal
July 11, 2016 7:00 AM UTC
GlaxoSmithKline and NIH’s Vaccine Research Center partnered to conduct laboratory studies of a Zika vaccine using the pharma’s self-amplifying mRNA (SAM) technology, which the pharma said could lead t...